Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Basil O. Ibe"'
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 4, Iss C, Pp 11-18 (2015)
Platelet activating factor (PAF) modulates ovine fetal pulmonary hemodynamic. PAF acts through its receptors (PAFR) in pulmonary vascular smooth muscle cells (PVSMC) to phosphorylate and induce nuclear translocation of NF-kB p65 leading to PVSMC prol
Externí odkaz:
https://doaj.org/article/52604e4eca4342e38805d9d5c40dc5fc
Publikováno v:
Medical Research Archives. 9
We studied effects of hypoxia and some modulators of PAFR–mediated signaling in fetal ovine arterial and venous smooth muscle cells to aid in explaining PAF regulation of fetal pulmonary hemodynamics in utero. PAFR, a G protein coupled receptor, is
Publikováno v:
Medical Research Archives. 8
We studied effect of chronic hypoxia (CH) on expression of platelet activating factor receptor (PAFR) by neonatal rats (pups). We hypothesized that PAFR antagonist will prevent pulmonary hypertension (PH) in pups exposed to CH. Pups were placed in an
Publikováno v:
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 310:R586-R595
Immaturity of respiratory controllers in preterm infants dispose to recurrent apnea and oxygen deprivation. Accompanying reductions in brain oxygen tensions evoke respiratory depression, potentially exacerbating hypoxemia. Central respiratory depress
Autor:
Basil O. Ibe, Lissette S. Renteria
Publikováno v:
The FASEB Journal. 32
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 4, Iss C, Pp 11-18 (2015)
Molecular Genetics and Metabolism Reports
Molecular Genetics and Metabolism Reports
Platelet activating factor (PAF) modulates ovine fetal pulmonary hemodynamic. PAF acts through its receptors (PAFR) in pulmonary vascular smooth muscle cells (PVSMC) to phosphorylate and induce nuclear translocation of NF-kB p65 leading to PVSMC prol
Publikováno v:
Pulmonary Circulation. 4:482-495
Initiation, progression, and resolution of vaso-occlusive pain episodes in sickle cell disease (SCD) have been recognized as reperfusion injury, which provokes an inflammatory response in the pulmonary circulation. Some 5-lipoxygenase (5-lox) metabol
Publikováno v:
Physiological Reports
Platelet‐activating factor (PAF) acting via its receptor (PAFR) is implicated in the pathogenesis of persistent pulmonary hypertension of the newborn (PPHN). Effects of long‐term oxygen therapy on newborn lung are not well understood; therefore,
Publikováno v:
International Archives of Allergy and Immunology. 158:18-26
Background: Racemic albuterol is a 50:50 mixture of the (R)- and (S)-enantiomers of albuterol. Its clinical efficacy resides in the (R)-enantiomer (levalbuterol). Studies have shown that (S)-albuterol induces human bronchial smooth muscle cell (HBSMC
Publikováno v:
Cell Proliferation. 41:208-229
Objective Platelet-activating factor (PAF) is implicated in pathogenesis of persistent pulmonary hypertension of the neonate (PPHN); PAF is a mitogen for lung fibroblasts. PAF's role in pulmonary vascular smooth muscle cell (PVSMC) proliferation and